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Abstract
Motivation: Mendelian randomization is an epidemiological technique that uses genetic variants as instru-
mental variables to estimate the causal effect of a risk factor on an outcome. We consider a scenario in
which causal estimates based on each variant in turn differ more strongly than expected by chance alone,
but the variants can be divided into distinct clusters, such that all variants in the cluster have similar causal
estimates. This scenario is likely to occur when there are several distinct causal mechanisms by which a
risk factor influences an outcome with different magnitudes of causal effect. We have developed an algo-
rithm MR-Clust that finds such clusters of variants, and so can identify variants that reflect distinct causal
mechanisms. Two features of our clustering algorithm are that it accounts for differential uncertainty in the
causal estimates, and it includes ‘null’ and ‘junk’ clusters, to provide protection against the detection of
spurious clusters.
Results: Our algorithm correctly detected the number of clusters in a simulation analysis, outperforming
methods that either do not account for uncertainty or do not include null and junk clusters. In an applied
example considering the effect of blood pressure on coronary artery disease risk, the method detected
four clusters of genetic variants. A post hoc hypothesis-generating search suggested that variants in the
cluster with a negative effect of blood pressure on coronary artery disease risk were more strongly related
to trunk fat percentage and other adiposity measures than variants not in this cluster.
Availability and Implementation: MR-Clust can be downloaded from https://github.com/cnfoley/mrclust.
Contact: sb452@medschl.cam.ac.uk
Supplementary Information: Supplementary data are available at Bioinformatics online.
1 Introduction
Genome-wide association studies have discovered many genetic variants
associated with various traits and conditions. Such genetic variants can aid
understanding of the biological mechanisms that influence traits (Plenge
et al., 2013). They can also be used to link modifiable traits to disease
outcomes. Due to random mating (that is, choice of partner is independent
of the genetic variants under investigation) and Mendel’s laws of segrega-
tion and independent assortment, genetic variants are typically distributed
independently of traits that they do not directly influence, and so can be
treated similarly to random treatment assignment in a randomized control-
led trial (Davey Smith and Ebrahim, 2003; Lawlor et al., 2008). Genetic
variants associated with a given trait are therefore plausible instrumental
variables (IVs) for that trait (Didelez and Sheehan, 2007). The use of gene-
tic variants as IVs to assess the causal effect of a risk factor on an outcome
is known as Mendelian randomization (Burgess and Thompson, 2015).
While the hypothesis of whether a risk factor has a causal effect on
an outcome can be assessed with a single valid IV (Didelez and Sheehan,
2007), most genetic variants do not explain enough variability in the risk
factor to have sufficient power to reliably detect a moderate-sized causal
effect. Additionally, it is prudent to use all relevant data to address the cau-
sal hypothesis of interest. Under strict parametric assumptions (described
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below), the causal estimates based on each valid IV will target the same
causal parameter – the average causal effect (Hernán and Robins, 2006).
Excess heterogeneity between causal estimates from different genetic vari-
ants is often interpreted as evidence that not all genetic variants are valid
instrumental variables (Verbanck et al., 2018).
However, it may be that different genetic variants influence the risk
factor in distinct ways, leading to heterogeneity between causal estimates
calculated using different variants. For example, several hundred genetic
variants have been demonstrated to be independently associated with blood
pressure (Evangelou et al., 2018). Different genetic variants may influence
blood pressure via distinct biological mechanisms. Alternatively, some
variants may have pleiotropic effects on traits that are causally upstream of
blood pressure rather than blood pressure directly. Or it may be that blood
pressure is in fact a composite trait consisting of multiple components that
is captured only as a single measurement. Variants that influence the risk
factor in a similar way are likely to have similar causal estimates.
Several previous attempts have been made to cluster genetic variants
that are associated with a given risk factor. Walter et al. (Walter et al., 2015)
took 32 genetic variants associated with body mass index (BMI) and divi-
ded the variants into four groups based on biological understanding of the
function of the variants. They then compared the causal estimates of BMI
on depression based on each group of variants. Udler et al. (Udler et al.,
2018) took 94 variants associated with Type 2 diabetes, and divided the
variants into 7 groups based on their associations with 47 diabetes-related
traits. Tanigawa et al. (Tanigawa et al., 2019) applied a truncated singular
value decomposition method to genetic association estimates from the UK
Biobank study to find clusters of variants having similar associations with
a range of traits.
In this paper, we introduce a method to cluster variants that have similar
causal estimates for the given risk factor and outcome. As we do not use
data on genetic associations with alternative traits to form the clusters, an
advantage of this approach is that genetic associations with traits can be
used to validate the division into clusters. If traits can be found that predict
cluster membership, this increases the plausibility that the clusters have a
biological interpretation. We refer to our method as MR-Clust.
Our manuscript is structured as follows. First, we provide an overview
of Mendelian randomization, and introduce the modelling assumptions
and notation used in the manuscript (Section 2). We also consider factors
that may lead to heterogeneity between causal estimates based on diffe-
rent genetic variants, and in particular investigate how this would lead to
clustered heterogeneity. Next, we introduce a statistical approach for dete-
cting clusters of variants with similar causal estimates, which are likely to
influence the risk factor in a similar way (Section 3). There are two distinct
aspects of our method over conventional applications of clustering. First,
we account for differential uncertainty in the causal estimates that we are
clustering. Secondly, we include a ‘junk’ cluster in our model, so that vari-
ants with estimates that do not fit into any clusters are included in the junk
cluster rather than any other cluster. We apply our method in a simulation
study, and to consider 180 independent genetic variants associated with
blood pressure at a genome-wide level of significance, and find clusters
in the causal estimates of blood pressure traits on coronary artery dise-
ase (CAD) risk (Section 4). We conclude by discussing the results of the
manuscript, and their application to epidemiological practice (Section 5).
2 System and methods
The aim of a Mendelian randomization analysis is to establish whether
there exists a causal relationship between a risk factor X and an outcome
Y using genetic variants Gj , j = 1, 2, . . . , J as instrumental variables.
An additional aim is to estimate the causal effect of the risk factor on the
outcome. In this section, we introduce assumptions and methods for IV
estimation, and discuss when the estimates based on different IVs will be
similar and when they will be different.
2.1 Instrumental variable assumptions
A genetic variant Gj is a valid instrumental variable if it satisfies three
assumptions:
• (relevance) it is associated with the risk factor,
• (exchangeability) its association with the outcome is not confounded,
and
• (exclusion restriction) it has no effect on the outcome except that medi-
ated via the risk factor (Greenland, 2000; Clarke and Windmeijer,
2012).
Under these assumptions, any association between the genetic variant and
the outcome is indicative of a causal effect of the risk factor on the outcome
(Baiocchi et al., 2014).
To estimate a causal parameter, we make further parametric assumpti-
ons of linearity and homogeneity in the relationships between the genetic
variant, risk factor, and outcome. Specifically:
E(X|Gj = g) = βXj0 + βXj g (1)
E(Y |Gj = g) = βY j0 + βY j g (2)
E(Y | do(X = x)) = θ0 + θ x (3)
where θ is the average causal effect of the risk factor on the outcome
(Angrist et al., 1996), and do(X = x) is Pearl’s do operator, meaning
that the risk factor is intervened on to take value x (Pearl, 2000). This
model can be illustrated as a directed acyclic graph (Figure 1).
Outcome
Genetic variant 1




Fig. 1. Directed acyclic graph illustrating relationships between three genetic variants that
are valid instrumental variables with a risk factor, outcome, and confounders of the risk
factor–outcome associations. The causal effect of the risk factor on the outcome is indicated
by θ.
It can be shown that θ can be estimated consistently as the ratio of the
estimated genetic association with the outcome divided by the estimated





which we call the ratio estimate of the jth variant. The standard error of













2ρ β̂Y j se(β̂Y j) se(β̂Xj)
β̂3Xj
(second order) (6)
where ρ is the correlation between the genetic association estimates β̂Y j
and β̂Xj . This parameter cannot be estimated directly from summarized
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data, but it will be zero in a two-sample setting (that is, the genetic asso-
ciations with risk factor and outcome are estimated in non-overlapping
datasets). When there is sample overlap, it can be specified by the user
based on the degree of overlap and the expected correlation between the
risk factor and outcome (Burgess et al., 2016a). If second-order weights
are used, then a sensitivity analysis for this parameter is advised.
We note that these parametric assumptions are sufficient, but not neces-
sary for the estimation of the average causal effect; weaker assumptions
have been proposed (Swanson and Hernán, 2013). Alternatively, under the
monotonicity assumption (the genetic variant increases the risk factor in
all individuals in the population, or decreases the risk factor in all indivi-
duals), a local average causal effect can be estimated (Imbens and Angrist,
1994). However, local average causal effects may differ between valid IVs.
We return to this point in the discussion.
2.2 Heterogeneity between causal estimates and clustered
heterogeneity
Even if the IV assumptions and parametric assumptions (1) and (2) are
satisfied for each genetic variant, it is plausible that the variant-specific
ratio estimates θ̂j differ by more than expected due to chance alone. We
are particularly interested in the case where there are distinct values of the
causal effect that are evidenced by multiple genetic variants, such that if
the sample size were to tend towards infinity, the ratio estimates would tend
towards a number of distinct values. We refer to this situation as clustered
heterogeneity. Clustered heterogeneity is interesting to investigate as the
identity of the genetic variants in the clusters may reveal information about
causal pathways relating to the outcome. Figure 2 illustrates how different
variants may be associated with the risk factor and outcome via different
mechanisms. This situation could arise in a number of ways:
1. Risk factor is a composite trait: The risk factor is not a single entity, but
in fact contains multiple components with distinct causal effects. For
example, although serum cholesterol concentration can be expressed
as a single measurement, evidence suggests that cholesterol carried
by low-density lipoprotein particles has a different causal relation-
ship to CAD risk compared with cholesterol carried by high-density
lipoprotein particles (Voight et al., 2012).
2. Multiple versions of treatment: The risk factor can be intervened on
in different ways, and each intervention leads to a different size of
change in the outcome. For example, interventions to lower BMI via
decreasing an individual’s caloric intake are likely to lead to less car-
diovascular benefit compared with interventions to increase metabolic
rate.
3. Pleiotropic effects via different biological pathways: Even if the risk
factor is a single trait and there is a single version of treatment, genetic
variants may associate with the risk factor via pleiotropic pathways,
which may influence the outcome directly (that is, not via the risk
factor).
In the first two situations, identifying features of genetic variants in
different clusters could help explain how the outcome is influenced by
different components of the risk factor or different causal pathways from
the risk factor, and hence inform our biological understanding of the causal
relationship between the risk factor and outcome. In the third situation,
the IV assumptions are violated, as the effects of the genetic variants
on the outcome are not completely mediated via the risk factor, but are
mediated via the pleiotropic variable. In this case, investigating traits that
associate preferentially with variants in different clusters could identify
intermediaries on the relevant causal pathway for each cluster.
In Appendix Section A, we provide some theoretical motivation that
clustered heterogeneity arises if and only if genetic variants in the same
cluster affect the outcome via the same distinct causal pathway, under
assumptions of linearity and homogeneity. However, it is impossible to
distinguish between the scenarios listed above on the basis of the genetic
associations with the risk factor and outcome alone. In particular, it is
not possible to distinguish situations 1 and 2 (in which the risk factor
causally affects the outcome) from situation 3 (in which the effect on
the outcome is via a pleiotropic mechanism). In the applied example, we
perform a post hoc exploratory analysis to investigate whether there are
traits that associate preferentially with variants in a given cluster, as an
attempt to interpret the mechanism represented by the cluster. Such a trait
may represent a pleiotropic variable that is influenced by variants in the
cluster, or variable downstream of a specific causal mechanism by which























Fig. 2. Scenarios that could lead to clustered heterogeneity, defined as the case where causal
estimates from multiple variants tend towards a number of distinct values as the sample size
increases. Clustered heterogeneity could arise in a number of ways: the mechanisms may
represent distinct components of the risk factor, or distinct pathways by which the risk
factor may influence the outcome, or intermediaries on the causal pathway from the genetic
variant to the outcome.
3 Algorithm
We proceed to introduce a statistical method for clustering causal estimates
from different genetic variants. We suppose that there are K + 2 disjoint
clusters of genetic variants: K substantive clusters, a null cluster, and a
junk cluster. The substantive clusters S1, . . . , SK have means θk , k =
1, . . . ,K. The null cluster S0 has mean θ0 = 0. The presence of the
null cluster ensures that genetic variants which do not suggest a causal
effect of the risk factor do not contribute to the estimates of the substantive
cluster means. The junk cluster SK+1 comprises all remaining genetic
variables that are not members of the other clusters. The presence of the
junk cluster ensures that genetic variants which do not fit into any of the
substantive clusters do not contribute to the estimates of the substantive
cluster means. Together, the null and junk clusters require there to be
substantial evidence of similarity of estimates from several genetic variants
to define a substantive cluster. This should minimize false positive findings
from the method. If we only used a single null cluster with a large variance
and no junk cluster, then variants having estimates close to the null may be
selected into one of the substantive clusters. However, there is no reason
why different genetic variants having null associations with the outcome
would share a common mechanism.
3.1 Mixture model
For each genetic variant j = 1, . . . , J , we introduce a cluster allocation
label zj , such that zj = k ⇐⇒ Gj ∈ Sk . For variants in the substantive
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and null clusters, we assume that the ratio estimate θ̂j for variant j in cluster
k follows a normal distribution with mean θk and standard deviation σ̂j ,
taken as the standard error of the jth ratio estimate:






for k = 0, 1, . . . ,K (7)
where Θ is a vector of the cluster means. For simplicity, we do not account
for uncertainty in the estimate of the standard error.
Following Crook et al. (Crook et al., 2018), we assume ratio estimates
for variants in the junk cluster follow a generalized t-distribution with
degrees of freedom ν = 4, mean µ taken as the sample mean of all the
ratio estimates (µ =
∑J
j=1 θ̂j/J), and scale parameter ψ taken as
| θ̂max − θ̂min | +2σ̂max, (8)
where θ̂max is the maximum of the ratio estimates, θ̂min is the minimum
of the ratio estimates, and σ̂max is the maximum of the standard errors
of the ratio estimates. We discuss the specification of this distribution in
Appendix Section B.
We obtain a mixture model for the ratio estimates θ̂j :
p(θ̂j | Θ, σ̂2j ) =
K+1∑
k=0




p(zj = k)p(θ̂j | Θ, σ̂2j , zj = k)
= π0 φ(θ̂j | 0, σ̂2j ) +
K∑
k=1
πk φ(θ̂j | θk, σ̂2j )+
πK+1 T (θ̂j), (9)
where πk is the mixture proportion for cluster k, φ(x | µ, σ2) denotes the
univariate normal density evaluated at xwith meanµ and variance σ2, and
T (x) denotes the generalized t-distribution evaluated at xwith degrees of
freedom ν = 4, and mean µ and scale parameter ψ as discussed above.
3.2 Parameter estimation via expectation maximization
The 2K + 1 parameters θk and πk (K cluster means and K + 2 propor-
tions, less one as the proportions must sum to one:
∑K+1
k=0 πk = 1) in
equation (9) are estimated via an expectation-maximization (EM) algori-
thm for a given number of substantive clusters K. We then estimate the
number of substantive clusters.
The log-likelihood of the sample data θ̂ (the ratio estimates) is

























We denote the maximum likelihood estimate (MLE) of the unknown para-
meters for a givenK as {θ∗K ,π∗K}. For ease of presentation, we drop the
index K in this section.
We index each iteration of the EM algorithm by the variable i so that
the pair {θ(i),π(i)} denotes estimates of the cluster means and mixture
proportions at the ith iteration of the algorithm. We stop updating the
parameters when the difference in log-likelihood between two iterations
falls below a user-defined tolerance δ.
We describe the algorithm in three main steps: (i) an initialization step
to obtain initial values of the parameters, and (ii) an expectation step and
(iii) a maximization step to update the parameter values.
Initialization step
Reliable estimation of the MLE might depend crucially on the initialization
of the parameters. To mitigate sensitivity to the initialization, our algorithm
computes multiple estimates of the MLE over various initializations of the
parameters. WhenK > 0, for each initialization we generate values for the
cluster means {θ(0)} via a k-means clustering of the data {θ̂}. We note
this method does not account for the uncertainty in the ratio estimates.
The initial mixture proportions {π(0)} are computed by first randomly
drawing values for the proportion of samples in the null and junk mixtures
{π(0)0 , π
(0)
K+1} from the range (0.05, 0.4). This ensures that the prior
probability of belonging to either the null or junk cluster is at least 10%
and at most 80%. The remaining parameters {π(0)1 , . . . , π
(0)
K } are then
computed as the proportion of observations assigned to each of the K
clusters from the k-means analysis multiplied by
(






Let Z denote the collection of cluster allocation labels {z1, z2, . . . , zJ}
for the variants j = 1, 2, . . . , J . Before updating the unknown parameters
in the maximization step, we first evaluate:
EZ|θ̂,θ(i),π(i)
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for k = K + 1. The rijk are sometimes referred to as the responsibilities
of the kth component for the jth observation (evaluated here at the ith
iteration of the EM algorithm).
Maximization step
Updates for the unknown parameters are obtained by maximizing equation








θ̂j |θk, σ̂j ,K
)
= 0, k = 1, 2, . . . ,K.













, k = 1, 2, . . . ,K. (14)
The update equation (14) resembles the inverse-variance weighted (IVW)
estimate of the causal effect of the risk factor on the outcome (Johnson,
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2013; Burgess et al., 2013). For a clusterS of ratio estimates that target the
same causal parameter (that is, the ratio estimates tend to the same causal
parameter as the sample size increases), the IVW estimate is the best











Comparing the above with (14), it follows that the EM update θ(i+1)k
is a re-weighted IVW estimate for the parameter θk . The weights are
multiplied by the responsibilities rijk which penalize the influence of
observations that are centred away from the current estimate of θ(i)k and/or
are highly diffuse (that is, σ̂j is large). In the large sample limit, as σ̂j → 0
for each j, it follows from equation (12) that
r∗jk =
{
1, if θ̂j → θk
0, if θ̂j 9 θk
(15)
=⇒ θ∗k = θ̂IVW (Sk) k = 1, 2, . . . ,K. (16)
where r∗jk denotes the responsibility of the kth component for the jth
observation computed at an iteration of the EM algorithm in which the
MLE is achieved.
The update equations for the mixture proportions πk are obtai-
ned by first modifying equation (11) to account for the constraint that∑K+1
k=0 πk = 1 by introducing a Lagrange multiplier, and then maximi-
















for k = 0, 1, . . . ,K + 1, where λ denotes the Lagrange multiplier.
3.3 Determining the number of clusters
We first calculate the MLEs {θ∗K ,π∗K} for each value of K ∈
{0, 1, . . . , J} possible substantive clusters present in the data. We esti-















This helps to avoid overparameterization, as the BIC penalizes models
which assume the data are generated from larger numbers of underlying
clusters.
Pseudocode outlining all steps in the MR-Clust algorithm is given in
Algorithm 1. In practice, if J is large, then we calculate the MLE and BIC
for increasing values of K starting at zero, and stop the algorithm once
there is evidence that the BIC is increasing monotonically with K.
4 Implementation
We perform a simulation study, comparing results from our MR-Clust
method to those obtained using three comparison methods. The Mclust
method (Scrucca et al., 2016) is a popular model-based clustering, clas-
sification, and density estimation method based on finite normal mixture
Algorithm 1 MR-Clust – Expectation Maximization (EM) Algorithm
Require: global convergence parameter δ, number of initializations I ,
number of variants J .
1: for K = 0, 1, . . . , J do
2: for initialization ι = 1, 2, . . . , I do
3: generate: cluster means θ(0)K and mixture proportions π
(0)
K .




















































}) > δ do









k = 0, 1, . . . ,K + 1.































16: compute: {θ(∗)K;ι∗ ,π
(∗)
K;ι∗}


















17: store: {θ(∗)K ,π
(∗)














where BIC(K∗) = minK=0,1,...,J BIC(K).
modelling. Unlike MR-Clust, Mclust does not account for observation-
specific uncertainty in the ratio estimates when assigning observations to
clusters, but rather estimates a cluster-specific variance parameter for each
cluster. It also does not incorporate null or junk clusters. We also com-
pare results against the T-Augmented Gaussian Mixture model (TAGM)
method, an extension of Mclust to include a junk component (Crook et al.,
2018). The original version of TAGM was a semi-supervised method,
which is relevant to its initial application to proteomic data, but is not rele-
vant here. We have adapted TAGM to exclude this aspect of the method
for comparison. We also compare with a version of the MR-Clust method
without a junk cluster. Unless indicated otherwise, all references to the
MR-Clust method relate to the implementation of the method with a junk
cluster.
The four methods are summarized in Table 1. By comparing these
methods, we show how features of the MR-Clust method, the null and junk
clusters and allowance for differential uncertainty in the observations, help
MR-Clust to correctly identify the number of clusters present in the data.
We then perform an applied analysis to demonstrate the method in practice.
Unless indicated otherwise, all references to the MR-Clust method relate
to the implementation of the method with a junk cluster.
4.1 Simulation: set-up and scenarios
We simulate data on genetic associations with a risk factor (β̂Xj ) and with
an outcome (β̂Y j ) for 90 genetic variants indexed by j. These associations
imitate coefficient estimates from linear regression of a continuous variable
with variance 1 on a single nucleotide polymorphism (SNP). A SNP can be
thought of as a binomial random variable taking values 0, 1, 2, representing
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Table 1. Summary of methods compared in the simulation study and applied
example.
Allows for Includes Includes
Method differential uncertainty? junk cluster? null cluster?
Mclust No No No
TAGM No Yes No
MR-Clust without junk Yes No Yes
MR-Clust with junk Yes Yes Yes
the number of minor alleles inherited from one’s parents at a particular















µβXj ∼ N (0, 1) ,
MAFj ∼ Uniform (0.05, 0.5) ,





where N is the notional sample size in which the genetic associations are
estimated, µβXj is the true genetic effect on the risk factor for variant j,
θj is the causal effect for variant j, MAFj is the minor allele frequency
of variant j, τ is an overdispersion parameter, and all distributions are
sampled independently.
We consider 4 scenarios, and simulate 1000 datasets in each scenario.
In Scenarios 1 and 2, there are no non-null clusters, and θj = 0 for
all j. In Scenarios 3 and 4, there are three non-null clusters θj = 0.4
for j = 1, . . . , 10, θj = −0.4 for j = 11, . . . , 30, θj = 0.8 for
j = 31, . . . , 70, a junk cluster in which the θj are drawn from a standard
normal distribution for j = 71, . . . , 80, and a null cluster θj = 0 for
j = 81, . . . , 90. In Scenarios 1 and 3, we set τ = 1 and in Scenarios 2
and 4, we set τ = 2. Scenario 1 represents a null scenario, in which all
genetic variants should be included in the null cluster. Scenario 2 represents
a variance-inflated null scenario, in which all genetic variants should be
included in either the null or junk clusters. These scenarios are considered
to assess whether the methods find spurious clusters where they do not
truly exist. In Scenario 3 and 4, the methods should find three clusters of
10, 20, and 40 variants each, and the other 20 variants should be included
in either the null or junk cluster. We repeat the simulation for sample sizes
of N = 1000 and N = 5000. Parameter values are displayed in Table 2.
Table 2. Number of variants and causal effect in each cluster for the simulation
study.
Number of variants Cluster causal effect (θj )
Scenarios Null Junk Cluster 1 2 3 Null Junk Cluster 1 2 3
1 & 2 90 0 0 0 0 0 - - - -
3 & 4 10 10 10 20 40 0 ∼ N (0, 1) 0.4 −0.4 0.8
In Scenarios 1 and 3, there is no excess heterogeneity in the genetic
associations with the outcome (τ = 1); in Scenarios 2 and 4, there is
excess heterogeneity (τ = 2).
4.2 Simulation results
Results from the simulation study are displayed in Figure 3 for a sample
size ofN = 1000 and Figure 4 for a sample size ofN = 5000. We present
the Rand index (top panel), which measures the similarity between the true
and estimated allocations into clusters (Rand, 1971), and the number of
clusters identified by each method (bottom panel). For comparability, for
the MR-Clust method we show the number of substantive clusters plus
one for the null cluster, as this is the number of clusters in the data as
well as the number that the Mclust and TAGM methods should detect.
We compare two versions of each method: (A) each variant is assigned to
the cluster with the greatest conditional probability (responsibility); and
(B) variants are only assigned to a cluster if the conditional probability
is ≥ 0.8, otherwise they are unassigned, and only substantive clusters
with at least 4 assigned variants are reported. Version (B) is recommended
to discourage the reporting of clusters that are evidenced by only a few
variants, which therefore may well be spurious. The thresholds of 0.8 for
the probability and 4 for the number of variants are arbitrary choices, but
gave good performance in the simulation setting. In version (A), all variants
contribute to the calculation of the Rand index. In version (B), only variants
in a cluster of at least 4 assigned variants contribute. In Scenarios 3 and 4,
genetic variants in the junk cluster do not contribute to the calculation of
the Rand index. This is to ensure a fair comparison between methods that
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Fig. 3. Results from the simulation study with sample sizeN = 1000 for MR-Clust (with
and without junk cluster), Mclust, and TAGM methods under four scenarios for the Rand
index (top panel) and the number of clusters identified (bottom panel). Points represent
median values across simulated datasets, and vertical bars represent the first and ninth
deciles. The horizontal line in the bottom panel represents the true number of clusters in
each scenario. Two versions of each method are presented: (A) each variant is assigned
to the cluster with the greatest conditional probability; (B) variants are only assigned to a
cluster if the conditional probability is ≥ 0.8 and clusters are only displayed if at least 4
variants are assigned to the cluster.
In Scenarios 1 and 2, both versions of MR-Clust with and without the
junk cluster perform well, identifying spurious clusters in less than 10%
of simulated datasets. In contrast, both the Mclust and TAGM methods
“mrclust_sb_200424_bioinf_cf_format” — 2020/8/6 — page 7 — #7
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Fig. 4. Results from the simulation study with sample sizeN = 5000 for MR-Clust (with
and without junk cluster), Mclust, and TAGM methods under four scenarios for the Rand
index (top panel) and the number of clusters identified (bottom panel). Points represent
median values across simulated datasets, and vertical bars represent the first and ninth
deciles. The horizontal line in the bottom panel represents the true number of clusters in
each scenario. Two versions of each method are presented: (A) each variant is assigned
to the cluster with the greatest conditional probability; (B) variants are only assigned to a
cluster if the conditional probability is ≥ 0.8 and clusters are only displayed if at least 4
variants are assigned to the cluster.
identify spurious clusters more often. The Rand index is close or equal to
1 for both versions of the MR-Clust method for all simulated datasets, but
substantially lower for the Mclust and TAGM methods. In Scenarios 3 and
4, MR-Clust continued to perform well in both scenarios, regularly iden-
tifying all four clusters in the data. Version (A) of the MR-Clust method
without the junk cluster occasionally detected an extra cluster, and version
(B) with and without a junk cluster sometimes failed to detect a cluster
in simulations with N = 1000. However, the Rand index was consisten-
tly high for both MR-Clust methods. In contrast, the Mclust and TAGM
methods had much lower Rand indices, and regularly failed to identify all
four clusters.
There was little difference in performance between the MR-Clust
method with a junk cluster and without a junk cluster. This is for two
main reasons. First, junk variants do not contribute to the Rand index.
Hence the method with a junk cluster is not commended for correctly assi-
gning these variants to the junk cluster rather than to a substantive cluster.
Secondly, junk variants are unlikely to have similar estimates. Hence it is
unlikely that the presence of junk variants will cause the method to incor-
rectly estimate the number of clusters. The presence of the junk cluster
reduces the number of false positive members of a cluster by providing a
fixed barrier to cluster entry. If evidence that a variant belongs to a cluster
does not reach the necessary threshold, then rather than assigning it to the
nearest cluster, it is allowed to not belong to any substantive cluster.
To further illustrate the MR-Clust method, we plot a kernel-weighted
density estimate of the distribution of estimated cluster means across
the 1000 datasets in Scenario 4 with a sample size of N = 5000
(Figure 5). On average, MR-Clust identified the correct cluster means at
{−0.4, 0, 0.4, 0.8} as well the correct proportions of variants belonging
to each cluster. We also plot the value of the log-likelihood at succes-
sive iterations of the EM algorithm corresponding to 6 initializations of
the parameters for a selected dataset generated under scenario 4 (Sup-
plementary Figure A1). In this example, the EM algorithm converged
to different values of the log-likelihood between the initializations. This
indicates some sensitivity of the method to the initial choice of mixture
proportions and cluster means, and motivates our use of multiple initia-
lizations in the algorithm. We investigated this property across a range
of further datasets and simulation scenarios, and usually found negligible
differences in MLEs across initializations. However, it is worth checking













Fig. 5. Kernel-weighted density plot of cluster means identified by MR-Clust method in
simulation scenario 4. Dashed vertical lines represent the true values of the cluster means.
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4.3 Applied example: blood pressure and coronary artery
disease risk
We illustrate our method by considering the relationship between blood
pressure and coronary artery disease (CAD) risk. Blood pressure is a heri-
table trait that is influenced by multiple biological pathways (Evangelou
et al., 2018; The International Consortium for Blood Pressure Genome-
Wide Association Studies, 2011). Elevated blood pressure is considered
to be a major risk factor for cardiovascular disease. We assess evidence
of clustered heterogeneity in Mendelian randomization analyses for the
causal effects of three blood pressure traits on CAD risk: systolic blood
pressure (SBP), diastolic blood pressure (DBP) and pulse pressure (PP).
Genetic associations with the blood pressure traits were obtained from
the International Consortium for Blood Pressure, and were estimated in
299 024 participants of European ancestry (Evangelou et al., 2018). To
avoid genetic associations being inflated due to winner’s curse, we only
considered genetic variants that had been demonstrated to be associated
with any blood pressure trait in a previous discovery genome-wide associa-
tion study (GWAS) at a genome-wide level of significance (p < 5×10−8).
For the analysis of each of the three blood pressure traits, we included all
variants additionally associated with the trait under analysis (that is, SBP,
DBP, or PP) in a replication dataset at a p-value threshold of 10−5. Vari-
ants were pruned to independence based on a distance threshold; only one
variant was included in the analysis per gene region. The variants were
all independently distributed (r2 < 0.01). For SBP, 121 variants were
included in the analysis; for DBP, 119 variants; and for PP, 85 variants.
Genetic associations with CAD risk were obtained from a meta-analysis of
122 733 cases and 424 528 controls primarily of European descent from the
CARDIoGRAMplusC4D consortium and UK Biobank (van der Harst and
Verweij, 2018). As the variants are strongly associated with the exposure,
any bias due to the small degree of sample overlap between the risk factor
and outcome datasets will be minimal (Burgess et al., 2016a). We applied
the MR-Clust method to assess evidence of clustered heterogeneity for
each of the three blood pressure traits on CAD risk separately.
Results
Results are displayed in Figure 6. An extract of the results is shown in
Table 3, and full results in Supplementary Table A2. Following the simu-
lation study, we present results according to version (A) of the method
(all variants assigned to a cluster: top panels) and version (B) (variants
assigned to a cluster if conditional probability≥ 0.8, only clusters with at
least 4 variants reported: bottom panels). Although the number of clusters
identified varies between SBP and DBP for version (A) of the method, four
clusters are reported in version (B) of the method for both traits. This is
despite the number and identity of variants varying between the analyses.
The largest cluster suggests a positive causal effect of blood pressure on
CAD risk. There are also two clusters suggesting a stronger positive causal
effect and one suggesting a weak negative effect. For PP, all three substan-
tive clusters in version (B) suggest a positive effect on CAD risk. This
suggests the presence of multiple mechanisms by which blood pressure
influences CAD risk.
We also performed analyses for SBP using the Mclust and TAGM
methods (Supplementary Figure A2). Each of the methods identified the
largest cluster that was also found by the MR-Clust method. However, both
methods combined all other variants into a single diffuse cluster, despite
these variants clearly not belonging to a single cluster. This illustrates
the value of using the variant-specific standard errors in judging whether
variants are compatible with cluster membership, rather than estimating a
cluster-specific heterogeneity without reference to these standard errors.
Table 3. Extract of summary of genetic variants and assignment to clusters
SBP DBP PP
rsid Cluster Mean Estimate SE Cluster Mean Estimate SE Cluster Mean Estimate SE
rs3184504 4 0.113 0.100 0.010 4 0.131 0.131 0.012 - - 0.390 0.037
rs12579720 4 0.113 0.119 0.021 4 0.131 0.132 0.024 - - - -
rs12940887 4 0.113 0.140 0.020 4 0.131 0.150 0.022 - - - -
rs6797587 4 0.113 0.124 0.019 4 0.131 0.157 0.024 - - - -
rs2521501 4 0.113 0.118 0.011 3 0.204 0.186 0.018 4 0.231 0.273 0.026
rs1063281 4 0.113 0.137 0.025 3 0.204 0.237 0.043 - - - -
rs112557609 4 0.113 0.121 0.025 - - - - - - 0.180 0.037
rs2972146 4 0.113 0.113 0.022 - - 0.202 0.039 - - - -
Separate analyses for systolic blood pressure (SBP), diastolic blood pres-
sure (DBP), and pulse pressure (PP): cluster number (greatest conditional
probability), cluster mean, ratio estimate for that variant, and its standard
error. The full results for all 180 variants are in Supplementary Table A2.
Dashes either indicate that the variant was not associated with the relevant
blood pressure trait at p < 10−5 (if the estimate is absent), or that the
variant was assigned to the null or junk cluster (if the estimate is present).
Fig. 6. Genetic associations with blood pressure traits (mmHg) and coronary artery dise-
ase risk (log odds) per additional blood pressure-increasing allele. Each genetic variant is
represented by a point. Error bars are 95% confidence intervals for the genetic associati-
ons. Colours represent the clusters, and dotted lines represent the cluster means. Top row:
method version (A) – each variant is assigned to the cluster with the greatest conditional
probability. Bottom row: method version (B) – variants are only assigned to a cluster if
the conditional probability is ≥ 0.8, and clusters are only displayed if at least 4 variants
are assigned to the cluster. Left column: systolic blood pressure; middle column: diastolic
blood pressure; right column: pulse pressure.
Hypothesis-generating search for causal mechanism
To demonstrate how clustering can reveal biological mechanisms in the
data, we focused on the genetic variants in the clusters for SBP and DBP
with a negative effect on CAD risk, and performed a post hoc hypothesis-
generating search of traits that associate with variants in these cluster as
an exploratory analysis. We consider this cluster as it is smaller than the
two positive clusters, and therefore more plausible that a single mecha-
nism may be driving cluster membership for the majority of variants. In
total, 10 genetic variants were assigned to this cluster with a conditio-
nal probability ≥ 0.8 in either the SBP or DBP analysis (Supplementary
Table A3). We looked up genetic associations in PhenoScanner, a database
of genetic associations with traits and diseases (Staley et al., 2016). For
each trait in turn, we considered whether each variant was associated with
that trait at p < 10−5 and p < 10−8, and report the true positive rate
(the proportion of variants in the cluster associated with the trait) and false
positive rate (the proportion of variants not in the cluster associated with
the trait). This functionality is built into the mrclust software package. In
total, we considered 3269 traits, although this includes several repeated
or synonymous traits, and blood pressure traits. Also, some traits only
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had association estimates for a limited number of variants. This makes it
difficult to correct for multiple comparisons. We therefore present results
under the caveat that no correction has been attempted.
Results are shown in Table 4. The trait “Trunk fat percentage” was
associated with 5 out of the 9 variants in the cluster that were present in
the dataset (true positive = 0.555), and only 14 out of the 169 variants
not in the cluster (false positive = 0.083). Similarly “Impedance of arm
right” was associated with 4 out of 9 variants in the cluster (true positive
= 0.444), and 15 out of the 169 variants not in the cluster (false positive =
0.089). Impedance is a measure of electrical resistance. It is greater when
the body part has a higher fat percentage. At a threshold of p < 10−8,
“Arm fat percentage” was associated with 3 out of 9 variants in the cluster
(true positive = 0.333) and only 4 out of the 169 variants not in the cluster
(false positive = 0.024).
Table 4. Traits from hypothesis-generating search of predictors of cluster
membership for cluster with negative causal effect.
Trait Threshold True positives (%) False positives (%) p-value
Trunk fat percentage 10−5 5/9 (55.5%) 14/169 (8.3%) 0.0022
Impedance of arm 10−5 4/9 (44.4%) 15/169 (8.9%) 0.0239
Arm fat percentage 10−8 3/9 (33.3%) 4/169 (2.4%) 0.0001
True positives is the fraction of variants in the cluster that are associated
with the trait at a p-value below the threshold. False positives is the fraction
of variants not in the cluster (that is, in any other cluster or not in a cluster at
all) that are associated with the trait at a p-value below the threshold. The p-
values in the rightmost column are for the hypothesis that association with
the trait is independent of cluster membership. P-values are calculated by
exact computation from the relevant hypergeometric distribution. We note
that while in total 10 variants were assigned to the target cluster, 1 variant
was not present in UK Biobank, the dataset in which the associations
with these particular traits were all estimated. Hence the number of true
positives is a fraction of 9, the number of variants present in UK Biobank.
This suggests that while most biological mechanisms associated with
increased blood pressure lead to increased CAD risk, there also may be
a biological mechanism associated with decreased blood pressure that
leads to increased CAD risk. This mechanism relates to measures of adi-
posity and fat distribution. However, the directions of association with
the adiposity measures were not consistent across variants in the cluster
(Supplementary Table A3).
We performed a multivariable Mendelian randomization analysis for
SBP on CAD risk additionally adjusting for body mass index to assess
mediation of the causal effect of SBP via adiposity (Burgess et al., 2017).
The coefficient for body mass index was imprecisely estimated and not
significantly different from zero, suggesting that body mass index is not
a strong mediator of the effect of SBP on CAD risk. Additionally, as a
negative control, we searched whether variants in the null cluster were
associated preferentially with any trait. No traits were preferentially asso-
ciated with variants in the null cluster, confirming our view that there is no
reason why variants in the null cluster should share a common mechanism.
We also performed the contamination mixture method for SBP on
CAD risk. This is a method for Mendelian randomization that allows the
possibility of multiple causal estimates in the analysis of a single risk factor
and outcome, but does not attempt to cluster genetic variants (Burgess et al.,
2020). The main utility of the contamination mixture method is to provide
a robust estimate of the causal effect evidenced by the largest subset of
genetic variants. The log-likelihood function from this method is plotted
in Supplementary Figure A3. In this case, the log-likelihood is unimodal.
While there is possibly a secondary peak in the log-likelihood at a negative
value of the causal estimate, this is not clear. This result provides empirical
evidence of the superiority of MR-Clust over the contamination mixture
method for detecting multiple causal estimates.
4.4 Applied example: HDL-cholesterol and coronary artery
disease risk
As a further example, we applied the MR-Clust method to an example
of high-density lipoprotein (HDL) cholesterol and CAD risk that we have
considered previously (Burgess et al., 2020). Results from the MR-Clust
method are displayed in Supplementary Figure A4. The method identified
three clusters of variants: two with negative causal estimates, and one with
a positive causal estimate. This is similar to results from the contamination
mixture method, which also had two negative maxima, although it was not
able to identify the cluster with a positive causal estimate.
5 Discussion
In this paper, we have discussed how causal estimates based on different
genetic variants in a Mendelian randomization investigation could differ.
In particular, we have introduced the notion of clustered heterogeneity, and
described how variants that influence the risk factor in different ways could
target distinct causal effect parameters. We have introduced the MR-Clust
method that detects clusters of variants having similar causal estimates.
There are several distinguishing features of this method: it accounts for
differential uncertainty in the causal estimates, and it includes null and junk
clusters, so that variants are only included in a substantive cluster if there
is strong evidence that they belong to that cluster. We demonstrated the
benefits of these features in a simulation study, showing how our method
outperforms clustering methods that do not have these features. Finally,
we illustrated an application of the method to analyse the causal effect of
blood pressure on CAD risk, demonstrating the existence of clusters of
genetic variants in an empirical example.
In developing this method, our strong concern was to avoid finding
spurious clusters of genetic variants that arise due to the chance similarity
of causal estimates from different variants. For this reason, we recommend
a conservative implementation of the method (version B), only assigning
a variant to a cluster if the conditional probability of cluster assignment
is ≥ 0.8, and only reporting a cluster if at least 4 variants satisfy this
criterion. A cluster is more robustly evidenced when it contains more
genetic variants, and particularly if a trait can be found that associates
specifically with variants in that cluster. We would advise particular caution
in the interpretation of a risk factor as causal on the basis of a small cluster
of variants, especially if the majority of variants are in the null cluster.
Our approach in this paper was to cluster genetic variants based on
their causal estimates for a single risk factor and outcome. There are seve-
ral advantages to this approach. First, there is a natural interpretation of
clusters in terms of the causal effect of the risk factor under investigation.
Secondly, as the causal estimate is the ratio of the genetic association with
the outcome to the genetic association with the risk factor, two variants
can appear in the same cluster even if one has weaker associations with
the risk factor and outcome, and the other has stronger associations. This
is important, as the magnitude of genetic associations is independent of
the causal pathway by which it influences the risk factor. Thirdly, as clu-
ster assignment is made on the basis of genetic associations with the risk
factor and outcome only, genetic associations with other traits can be used
to validate cluster membership, and to explore distinct mechanisms by
which the risk factor influences the outcome. If data on genetic associa-
tions with multiple traits were used to cluster variants, then the clusters
might be more precisely defined, but it would not be possible to determine
which traits were driving the division into clusters without further analysis.
We have previously demonstrated that a group of variants having similar
causal estimates for the effect of HDL-cholesterol on CAD risk also had
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a distinct pattern of associations with blood cell traits, although without
using a formal clustering method (Burgess et al., 2020). The associati-
ons with blood cell traits suggested a causal pathway relating to platelet
aggregation.
In order to interpret causal estimates as average causal effects, we made
parametric assumptions of linearity and homogeneity. We have discussed
these assumptions at length previously (Burgess et al., 2016b). Briefly,
the associations of genetic variants with traits are typically small, and so
while substantial non-linearity is plausible when considering the causal
relationship between a risk factor and outcome across the range of the risk
factor distribution, it is less likely when considering the impact of small
changes in the average level of the risk factor, as estimated in Mendelian
randomization. If the homogeneity assumption is not satisfied, then cau-
sal estimates can be interpreted as local average causal effects under the
assumption of monotonicity. The monotonicity assumption is generally
plausible for genetic variants, as it is difficult to conceive a biological rea-
son why a genetic variant would increase the risk factor in one subset of the
population, and decrease it in another. This provides another reason why
causal estimates from different genetic variants may differ, as the complier
populations corresponding to different genetic variants may differ. How-
ever, we believe differences in local average causal effects for different
complier populations are unlikely to be substantial in practice. A claim
that there are multiple causal pathways from the risk factor to the outcome
is more plausible when traits can be found that predict cluster member-
ship, particularly if these traits are potential mediators or moderators of
the causal effect of the risk factor.
This is not the first method to consider clustering of genetic variants
based on their associations with various traits. Previous researchers have
considered Bayesian nonnegative matrix factorization (Udler et al., 2018),
truncated singular value decomposition method (Tanigawa et al., 2019),
and hierarchical clustering approaches (Ruth et al., 2020). We believe
that our method has important properties when clustering variants based
on their causal estimates, which are calculated using associations with
a single risk factor and outcome. A potential extension of this framew-
ork could consider clustering variants based on associations with multiple
traits. There has also been previous work in the Mendelian randomization
literature that assigns variants into subgroups. The MRMix method (Qi
and Chatterjee, 2019) takes a large number of genetic variants and divides
the variants into four subgroups: those associated with the risk factor and
outcome through a causal mechanism, those associated with the risk factor
and outcome through a pleiotropic mechanism, those associated with the
outcome alone, and those associated with neither the risk factor nor the
outcome. The motivation of the MRMix method is to provide a single
estimate of a single causal effect that is robust to some genetic variants
not being valid instruments. Our method has a very different objective,
which is to find clusters of variants having similar causal effects, rather
than to label some variants as valid and others as invalid. Another related
method is the MR-TRYX method (Cho et al., 2020). This method also
considers whether different genetic variants have similar causal estimates,
but instead of focusing on subgroups of variants with similar estimates
(as we do here), it instead focuses on individual outliers, and tries to find
associations of those variants that may explain why they are outliers. We
believe that in most cases it will not be possible to demonstrate convincin-
gly that a single covariate association explains why a genetic variant is
an outlier, and hence our approach, which tries to find groups of variants
having similar estimates and then find what is similar between them in
terms of their genetic associations, is preferable.
In conclusion, we have proposed a method in the context of Mende-
lian randomization that clusters genetic variants associated with a given
risk factor according to the variant’s associations with the risk factor and
outcome. We have shown theoretically and empirically how the method can
help elucidate distinct causal pathways by which the risk factor influences
the outcome.
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